Psychotic disorders are severe mental health disorders that cause changes in a person's way of thinking and their perception. Patients often have trouble differentiating between what they perceive and reality. Different types of psychotic disorders include schizophrenia, bipolar disorder, substance-induced psychotic disorder, delusional disorder, and brief psychotic disorder. However, this market only represents the sales of antipsychotic drugs that are used to treat schizophrenia and bipolar disorder.
Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.
Company examples: Otsuka Pharmaceutical, Lundbeck, AbbVie, Allergan plc, Recordati S.p.A., Gadeon Richter, Sumitomo Pharma, Johnson & Johnson / Janssen, Vanda Pharmaceuticals, Alkermes, Eli Lilly, AstraZeneca, and Intra-Cellular Therapies
Notes: Data was converted from local currencies using average exchange rates of the respective year.
Most recent update: Jun 2024
Source: Statista Market Insights
Most recent update: Jun 2024
Source: Statista Market Insights
Most recent update: Jun 2024
Source: Statista Market Insights
The Psychotic Disorders market in Zimbabwe is experiencing significant growth and development due to several key factors.
Customer preferences: Customers in Zimbabwe are increasingly seeking treatment and support for psychotic disorders. This is partly due to a growing awareness and understanding of mental health issues in the country. As a result, there is a higher demand for psychiatric services and medications to manage psychotic disorders.
Trends in the market: One of the main trends in the Psychotic Disorders market in Zimbabwe is the increasing availability and accessibility of mental health services. The government has recognized the importance of addressing mental health issues and has taken steps to improve access to care. This includes the establishment of specialized psychiatric hospitals and the training of more mental health professionals. As a result, more individuals are able to receive the necessary treatment for their psychotic disorders. Another trend in the market is the growing use of psychotropic medications. With the increased availability of these medications, healthcare providers are able to better manage and treat psychotic disorders. This has led to improved outcomes for patients and a higher demand for these medications.
Local special circumstances: Zimbabwe has faced significant economic challenges in recent years, which have had an impact on the healthcare system. However, despite these challenges, the government has prioritized mental health and has allocated resources to improve services in this area. This commitment to mental health has created a supportive environment for the growth of the Psychotic Disorders market in Zimbabwe.
Underlying macroeconomic factors: The economic situation in Zimbabwe has had both positive and negative effects on the Psychotic Disorders market. On one hand, the economic challenges have led to increased stress and anxiety among the population, which can contribute to the development of psychotic disorders. This has created a larger customer base for mental health services and medications. On the other hand, the economic challenges have also put strain on the healthcare system and limited resources for mental health services. This has created barriers to access for some individuals, particularly those in rural areas or with limited financial means. However, the government's commitment to improving mental health services has helped to mitigate some of these challenges and ensure that individuals can still receive the care they need. In conclusion, the Psychotic Disorders market in Zimbabwe is experiencing growth and development due to increasing customer preferences for mental health services, the availability of specialized care and medications, the government's commitment to mental health, and the economic challenges that have created a larger customer base for these services.
Most recent update: Jun 2024
Source: Statista Market Insights
Data coverage:
Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.Modeling approach / Market size:
Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.Additional Notes:
The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.Notes: Based on data from IMF, World Bank, UN and Eurostat
Most recent update: Sep 2024
Source: Statista Market Insights